2025-10-09 - Analysis Report
Okay, here's an analysis of Northrop Grumman (NOC) based on the data you provided.

## Northrop Grumman (NOC) Stock Analysis

Northrop Grumman Corp. is an aerospace and defense technology company, known for its contributions to global security.

### 1. Performance vs. S&P 500 (VOO)

*   **NOC Cumulative Return:** 65.55%
*   **VOO Cumulative Return:** 99.62%
*   **Performance Deviation:**
    *   Current Deviation: -41.8% (NOC is underperforming VOO)
    *   Relative Deviation: 11.7% (This indicates that the current deviation is relatively close to the lowest end of its historical range compared to VOO.)

**Analysis:** NOC has significantly underperformed the S&P 500 based on the cumulative return data. The relative deviation suggests that this underperformance is near its historical worst compared to the benchmark, meaning that from relative stand point, it's not a good choice now.

**Alpha and Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
|------------|---------|---------|--------|------|--------|
| 2015-2017  | 46.0%   | 65.6%   | 17.0%  | 0.0  | 43.9   |
| 2016-2018  | -2.0%   | 74.3%   | -17.0% | 0.0  | 35.1   |
| 2017-2019  | 17.0%   | 79.2%   | -5.0%  | 0.9  | 49.2   |
| 2018-2020  | -28.0%  | 79.9%   | -52.0% | 0.8  | 43.6   |
| 2019-2021  | 43.0%   | 79.9%   | -4.0%  | 0.8  | 55.4   |
| 2020-2022  | 18.0%   | 79.9%   | 19.0%  | 0.3  | 78.1   |
| 2021-2023  | 24.0%   | 82.7%   | 23.0%  | 0.2  | 67.0   |
| 2022-2024  | -15.0%  | 82.7%   | -36.0% | 0.2  | 67.2   |
| 2023-2025  | 15.0%   | 82.1%   | -49.0% | 0.1  | 91.3   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly across different periods, indicating volatility in NOC's returns.
*   **MDD:** The Maximum Drawdown figures are consistently high, suggesting substantial potential losses during downturns.
*   **Alpha:** Alpha is highly variable, indicating periods of both outperformance and underperformance compared to the market. The most recent period (2023-2025) shows a significant negative alpha, suggesting substantial underperformance.
*   **Beta:** Beta values are generally low (close to 0 in the beginning and later between 0.1 and 0.9), suggesting that NOC's price is not as sensitive to market movements as the S&P 500.

### 2. Recent Price Action

*   **Current Price:** $637.95
*   **Previous Close:** $621.63
*   **Change:** 2.63%
*   **5-day Moving Average:** $618.53
*   **20-day Moving Average:** $592.89
*   **60-day Moving Average:** $581.57

**Analysis:** NOC's price is above all its short-term and medium-term moving averages, indicating a short-term upward trend. The significant price increase from the previous close suggests a strong positive movement.

### 3. Market Risk Indicators

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 92.06 (Overbought)
*   **PPO:** 0.7574
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (1 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00)"
*   **Delta Previous Relative Divergence (20-day):** 1.8 (+) (Short-term increase)
*   **Expected Return:** -21.3% (Expected underperformance vs. S&P 500 over the long term)

**Analysis:**

*   Despite the High Investment Recommended MRI, the RSI indicates that the stock is overbought, suggesting a potential pullback.
*   The positive change in relative divergence supports the recent upward price movement.
*   The negative expected return suggests that long-term investment might underperform the S&P 500.
*   The large price change from the previous close ($621.63 to $637.95) confirms a significant positive movement, which needs to be taken into account.

### 4. Recent News & Significant Events

*   **Autonomous Docking Milestone:** (Oct 9) Successful autonomous docking boosted the stock.
*   **Price Target Increase:** (Oct 8) Articles suggest potential for the stock to hit $700.
*   **Analyst Upgrade:** (Oct 8) Deutsche Bank upgraded Northrop Grumman to Buy.

**Analysis:** Recent news is overwhelmingly positive, with successful milestones, analyst upgrades, and price target increases all contributing to positive sentiment.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 2.05)
*   **Target Price:** Average $622.50 (lower than current price), High $769.00, Low $510.00
*   **Recent Rating Changes:** Upgrades indicate positive sentiment.

**Analysis:** The analyst consensus is generally positive, with a "Buy" rating. However, the average target price is *below* the current price, suggesting limited upside potential based on analyst estimates. However, with the recent target price increase articles, analysts may soon revise their estimates.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출       |
|--------------|------|------------|
| 2025-07-22   | 8.17 | 10.35 B$   |
| 2025-04-22   | 3.33 | 9.47 B$    |
| 2024-10-24   | 7.02 | 10.00 B$   |
| 2024-07-25   | 6.37 | 10.22 B$   |
| 2025-07-22   | 6.37 | 10.22 B$   |

**Analysis:**

*   **Mixed EPS Performance:** EPS has fluctuated over the past few quarters. The most recent EPS is strong, but previous quarters show variability.
*   **Stable Revenue:** Revenue has been relatively stable, generally above $10 billion per quarter.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-06-30   | $10.35B   | 21.35%        |
| 2025-03-31   | $9.47B    | 16.69%        |
| 2024-12-31   | $10.69B   | 18.08%        |
| 2024-09-30   | $10.00B   | 21.07%        |
| 2024-06-30   | $10.22B   | 21.44%        |

**Capital and Profitability:**

| Quarter      | Equity     | ROE      |
|--------------|------------|----------|
| 2025-06-30   | $15.47B   | 7.59%    |
| 2025-03-31   | $14.98B   | 3.21%    |
| 2024-12-31   | $15.29B   | 8.27%    |
| 2024-09-30   | $14.75B   | 6.96%    |
| 2024-06-30   | $14.30B   | 6.57%    |

**Analysis:**

*   **Consistent Revenue:** Revenue has been fairly consistent, indicating stable demand for Northrop Grumman's products and services.
*   **Fluctuating Profit Margins:** Profit margins have varied somewhat, indicating potential variability in cost management or pricing power.
*   **Stable Equity:** Equity has remained relatively stable, suggesting a solid financial foundation.
*   **Variable ROE:** Return on Equity (ROE) has fluctuated, indicating variations in the company's ability to generate profits from shareholder equity.

### 7. 종합적인 Analysis

*   **Recent Positive Momentum:** The stock has experienced a recent surge in price, driven by positive news, analyst upgrades, and successful milestones.
*   **Overbought Condition:** The high RSI suggests the stock may be overbought and due for a pullback.
*   **Analyst Sentiment:** Analysts are generally positive, but the average target price indicates limited upside. However, the recent upgrades suggest these targets may be revised.
*   **Underperformance vs. S&P 500:** NOC has underperformed the S&P 500, and the expected return suggests this trend may continue in the long term.
*   **Strong Fundamentals:** NOC has demonstrated strong and stable revenue with variable profitability.

**Overall Recommendation:**

Given the recent positive momentum and analyst upgrades, NOC might present a short-term trading opportunity. However, the overbought condition and long-term underperformance compared to the S&P 500 suggest caution for long-term investors. Investors should carefully consider their risk tolerance and investment goals before making a decision. Specifically, it's important to note the discrepancy between current positive analyst sentiment and the negative long-term expected return. This discrepancy could indicate a need for further investigation into the factors driving the negative expected return.
